Naturalsociety, By Elizabeth Renter, 10/14/2013

Nearly one-third (32.7%) of American women have high blood pressure, according to the Centers for Disease Control and Prevention. While many individuals with high blood pressure change their diet and increase activity levels to keep blood pressure under control, others are content to rely wholly on the chemical concoction prescribed by their doctor. There are many problems with blood pressure medications though—one of which is a significant increase in the risk of breast cancer for women.

According to a recent study published in the journal Internal Medicine, women taking calcium channel blockers like nicardipine (Cardene) and amlodipine (Norvasc) have about a 250 percent greater risk of developing some types of breast cancer than other women.

Activist Post, By: Jon Rappoport, 10/11/2013

The disease/treatment/profit machine requires more and more diseases, even if they aren’t real. Here is an unspoken but largely accepted medical notion of what a disease is: A group of physical symptoms shared by many people, which has a single cause. For example, take the flu. Wikipedia lists the common symptoms: chills, fever, muscle pains, headache, coughing. For each type of flu, there is single virus announced as the cause. E.g., Swine Flu; H1N1 virus. Drug companies develop medicines and vaccines to kill the virus or prevent it from gaining a foothold in the body. They sell the drugs and vaccines. Profits soar. Nice and neat. Of course, many doctors don’t bother to test patients to see if they have a disease like seasonal flu. It’s too time consuming to take a blood sample and send it to a lab and wait for the results. So the doctor makes an eyeball diagnosis based on symptoms and the season of the year.

For more on this story visit www.activistpost.com

Alternet.org, By: Bruce E. Levine, 09/19/2013

Fascinating research reveals that some people who suffer a psychotic break do better without a lifetime of medication. It was an amazing victory for mental health treatment reform activists and one investigative reporter: on Aug. 28, 2013, National Institute of Mental Health director Thomas Insel announced that psychiatry’s standard treatment for people diagnosed with schizophrenia and other psychoses needs to change. After examining two long-term studies on schizophrenia and psychoses, Insel came to what was previously considered a radical conclusion: in the long-term, some individuals with a history of psychosis do better off medication.

Insel finally recognized what mental health treatment reform activists and investigative reporter Robert Whitaker have been talking about for years—the research shows that American psychiatry’s standard treatment protocol has hurt many people who could have been helped by a more selective and limited use of drugs, and a more diverse approach such as the one used in Finland, which has produced the best long-term outcomes in the developed world.

By: AllianceForNaturalHealth, 09/10/2013

The EPA, on the other hand, allows its widespread use as a germ killer in clothing, bedding, cosmetics, electric shavers, baby bottles, and food containers. Silver has been used as an antimicrobial for thousands of years—that’s why forks, spoons, and platters were traditionally made out of silver. Nanosilver, however, sprang out of the new science of nanomaterials, which involves creating objects smaller than 100 nanometers. (A nanometer is a billionth of a meter.) For example, the period at the end of this sentence is a million nanometers wide.

Newyorker.com, By: Gary Greenberg, 09/03/2013

It’s been just over twenty-five years since Prozac came to market, and more than twenty per cent of Americans now regularly take mind-altering drugs prescribed by their doctors. Almost as familiar as brands like Zoloft and Lexapro is the worry about what it means that the daily routine in many households, for parents and children alike, includes a dose of medications that are poorly understood and whose long-term effects on the body are unknown. Despite our ambivalence, sales of psychiatric drugs amounted to more than seventy billion dollars in 2010. They have become yet another commodity that consumers have learned to live with or even enjoy, like S.U.V.s or Cheetos.